Drug Pipeline

ABBV-932 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT06849791
A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult…		 Trial completed
2026-06-05 NCT06849791
A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult…		 date change Primary completion pushed: 2026-03 -> 2026-05-08
2026-06-05 NCT06849791
A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult…		 date change Completion pushed: 2026-03 -> 2026-05-08
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06846320 Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added… Generalized Anxiety Disorder (GAD) Recruiting
NCT07220460 Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive… Bipolar I or II Disorder Recruiting
Phase 1
NCT06953934 A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants Healthy Volunteer Recruiting
Sponsors Running ABBV-932 Trials
AbbVie (3)
Disease Areas
Anxiety (1) Bipolar Disorder (1)
Get alerts when ABBV-932 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free